Literature DB >> 17728067

Cryptosporidium and Giardia as foodborne zoonoses.

H V Smith1, S M Cacciò, N Cook, R A B Nichols, A Tait.   

Abstract

Cryptosporidium and Giardia are major causes of diarrhoeal disease in humans, worldwide and are major causes of protozoan waterborne diseases. Both Cryptosporidium and Giardia have life cycles which are suited to waterborne and foodborne transmission. There are 16 'valid'Cryptosporidium species and a further 33+ genotypes described. Parasites which infect humans belong to the Giardia duodenalis "type", and at least seven G. duodenalis assemblages are recognised. Cryptosporidium parvum is the major zoonotic Cryptosporidium species, while G. duodenalis assemblages A and B have been found in humans and most mammalian orders. In depth studies to determine the role of non-human hosts in the transmission of Cryptosporidium and Giardia to humans are required. The use of harmonised methodology and standardised and validated molecular markers, together with sampling strategies that provide sufficient information about all contributors to the environmental (oo)cyst pool that cause contamination of food and water, are recommended. Standardised methods for detecting (oo)cysts in water are available, as are optimised, validated methods for detecting Cryptosporidium in soft fruit and salad vegetables. These provide valuable data on (oo)cyst occurrence, and can be used for species and subspecies typing using appropriate molecular tools. Given the zoonotic potential of these organisms, epidemiological, source and disease tracking investigations involve multidisciplinary teams. Here, the role of the veterinarian is paramount, particularly in understanding the requirement for adopting comprehensive sampling strategies for analysing both sporadic and outbreak samples from all potential non-human contributors. Comprehensive sampling strategies increase our understanding of parasite population biology and structure and this knowledge can be used to determine what level of discrimination is required between isolates. Genetic exchange is frequent in C. parvum populations, leading to recombination between alleles at different loci, the generation of a very large number of different genotypes and a high level of resolution between isolates. In contrast, genetic exchange appears rare in Cryptosporidium hominis and populations are essentially clonal with far fewer combinations of alleles at different loci, resulting in a much lower resolution between isolates with many being of the same genotype. Clearly, more markers provide more resolution and high throughput sequencing of a variety of genes, as in multilocus sequence typing, is a way forward. Sub-genotyping tools offer increased discrimination, specificity and sensitivity, which can be exploited for investigating the epidemiology of disease, the role of asymptomatic carriers and contaminated fomites and for source and disease tracking for food and water contaminated with small numbers of (oo)cysts.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17728067     DOI: 10.1016/j.vetpar.2007.07.015

Source DB:  PubMed          Journal:  Vet Parasitol        ISSN: 0304-4017            Impact factor:   2.738


  47 in total

1.  Investigations and comparative detection of Cryptosporidium species by microscopy, nested PCR and LAMP in water supplies of Ordu, Middle Black Sea, Turkey.

Authors:  Z Koloren; I Sotiriadou; P Karanis
Journal:  Ann Trop Med Parasitol       Date:  2011-12

2.  Multiplex assay detection of immunoglobulin G antibodies that recognize Giardia intestinalis and Cryptosporidium parvum antigens.

Authors:  Jeffrey W Priest; Delynn M Moss; Govinda S Visvesvara; Cara C Jones; Anna Li; Judith L Isaac-Renton
Journal:  Clin Vaccine Immunol       Date:  2010-09-28

3.  Comparison between two commercially available serological tests and polymerase chain reaction in the diagnosis of Cryptosporidium in animals and diarrhoeic children.

Authors:  Yosra A Helmy; Jürgen Krücken; Karsten Nöckler; Georg von Samson-Himmelstjerna; Karl-H Zessin
Journal:  Parasitol Res       Date:  2013-11-13       Impact factor: 2.289

4.  Molecular detection of Cryptosporidium spp. and the occurrence of intestinal parasites in fecal samples of naturally infected dogs and cats.

Authors:  Marta Elena Machado Alves; Felippe Danyel Cardoso Martins; Patrícia Bräunig; Felipe Lamberti Pivoto; Luís Antonio Sangioni; Fernanda Silveira Flores Vogel
Journal:  Parasitol Res       Date:  2018-06-29       Impact factor: 2.289

5.  Modeling and kinetic characterization of wastewater disinfection using chlorine and UV irradiation.

Authors:  Brahmi Mounaouer; Hassen Abdennaceur
Journal:  Environ Sci Pollut Res Int       Date:  2016-07-16       Impact factor: 4.223

6.  Microbial Indicators, Opportunistic Bacteria, and Pathogenic Protozoa for Monitoring Urban Wastewater Reused for Irrigation in the Proximity of a Megacity.

Authors:  María Alejandra Fonseca-Salazar; Carlos Díaz-Ávalos; María Teresa Castañón-Martínez; Marco Antonio Tapia-Palacios; Marisa Mazari-Hiriart
Journal:  Ecohealth       Date:  2016-09-28       Impact factor: 3.184

7.  The prevalence of Cryptosporidium species in diarrhoeic lambs in Kars province and potential risk factors.

Authors:  Bariş Sari; Mükremin Ozkan Arslan; Yunus Gicik; Murat Kara; Gencay Taşkin Taşçi
Journal:  Trop Anim Health Prod       Date:  2008-11-05       Impact factor: 1.559

8.  Temporal and spatial dynamics of Cryptosporidium parvum infection on dairy farms in the New York City Watershed: a cluster analysis based on crude and Bayesian risk estimates.

Authors:  Barbara Szonyi; Susan E Wade; Hussni O Mohammed
Journal:  Int J Health Geogr       Date:  2010-06-17       Impact factor: 3.918

9.  Spinacia oleracea L. leaf stomata harboring Cryptosporidium parvum oocysts: a potential threat to food safety.

Authors:  Dumitru Macarisin; Gary Bauchan; Ronald Fayer
Journal:  Appl Environ Microbiol       Date:  2009-11-20       Impact factor: 4.792

10.  Characteristics and risk factors for symptomatic Giardia lamblia infections in Germany.

Authors:  Werner Espelage; Matthias an der Heiden; Klaus Stark; Katharina Alpers
Journal:  BMC Public Health       Date:  2010-01-28       Impact factor: 3.295

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.